Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) – Equities research analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for Harmony Biosciences in a research report issued to clients and investors on Wednesday, November 1st. Cantor Fitzgerald analyst C. Duncan now forecasts that the company will post earnings per share of […]